Lyrica Sales Data

Rank 18 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Lyrica U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 18 2.82% 1.10%
Q3 2013 18 (1) 6.13% -6.03%
Q2 2013 19 3.53% 3.09%
Q1 2013 19 (2) 8.10% 0.29%
Q4 2012 21 2.36% 2.17%
Q3 2012 21 (7) 9.94% 2.12%
Q2 2012 28 -0.78% -0.45%
Q1 2012 28 (3) 6.04% -2.02%
Q4 2011 31 (2) 1.23% 1.25%
Q3 2011 29 -2.94% -2.10%
Q2 2011 29 (1) 0.72% 0.74%
Q1 2011 30

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
October 28, 2013Lyrica May Ease Pain for Depressed Fibromyalgia Patients
May 4, 2012Pfizer Stops Phase 3 Trial Of Lyrica (pregabalin) Capsules CV In Neuropathic Pain Associated With HIV Neuropathy
April 29, 2009Common Drug Eases Restless Legs Syndrome
Hide
(web3)